Federal Official Gazette
No updates
ANS news
Cosaúde evaluates incorporation of technologies into the Rol
At its 54th technical meeting, the Commission held a preliminary discussion of:
amendment of DUT 110.39 – Molecular DNA Analysis, for intellectual disability of undetermined cause;
21-gene test for genomic expression profiling of breast tumors;
implantation of a device for cardiac contractility modulation; and
contributions related to the update of DUT 52 – Digital Mammography.
The first three proposals will proceed to public participation before the final decision by the Board of Directors (DICOL). The amendment concerning digital mammography will go directly to final approval by the Board of Directors (DICOL). https://www.gov.br/ans/pt-br/assuntos/noticias-1/periodo-eleitoral/cosaude-avalia-incorporacao-de-tecnologias-no-rol
Open public consultations
- CP 175. Subject matter: criticisms and suggestions regarding the preliminary recommendations not to incorporate the technologies covered by UAT No. 199 – Cholangioscopy; UAT No. 200 – Next-generation sequencing (NGS) panel; and UAT No. 206 – Tepotinib hydrochloride. Deadline: Aug 12, 2026 to Aug 31, 2026. The deadline ends today. https://www.gov.br/ans/pt-br/assuntos/noticias-1/periodo-eleitoral/consulta-publica-175-ans-recebe-contribuicoes-para-atualizacao-do-rol
Scheduled public hearings
There are no future public hearings scheduled.
Open public calls for input
There is no open public call for input.
Open public calls
There are no open public calls.
Other news
AI cannot decide alone on denial of health plan coverage, says ANS
Source: brasil247.com · read the full article
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.